DUBLIN–(BUSINESS WIRE)–$PRTA #Prothena–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on…
Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking. What You Should Know: – Advancements in accelerating early Alzheimer’s disease…
